Cresset Asset Management »

Silverback Therapeutics shares owned by Cresset Asset Management

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Cresset Asset Management from 13F filings

Historical chart of Cresset Asset Management investment in Silverback Therapeutics

Jul 2024Aug 2024Sep 2024Oct 2024Nov 2024Dec 2024Jan 2025200k250k300k350k25k26k27k28k
Value ($)Share countHistorical SPRY position of Cresset Asset Management Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Cresset Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Cresset Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $293k 28k 10.55
2024-09-30 $355k 25k 14.50
2024-06-30 $208k 25k 8.51

More positions owned by Cresset Asset Management

Arista Networks Com Shs
Spdr S&p 500 Etf Tr Tr Unit Put Option (Principal) (SPY)
Ishares Tr Core S&p500 Etf Put Option (Principal) (IVV)
Apple (AAPL)
Invesco Exchange Traded Fd T S&p500 Eql Wgt Put Option (Principal) (RSP)
Ishares Tr Core S&p Scp Etf Put Option (Principal) (IJR)
Meta Platforms Cl A Put Option (META)
Ishares Tr S&p 100 Etf (OEF)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Microsoft Corporation (MSFT)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Cresset Asset Management

Top funds holding Silverback Therapeutics

RA Capital Management
Deerfield Management Company
OrbiMed Advisors
BlackRock
Sr One Capital Management
Alliancebernstein
Vanguard Group
State Street Corporation
Franklin Resources
Alyeska Investment Group
Geode Capital Management
Woodline Partners
Nextech Invest
FMR
Citadel Advisors

View all funds holding Silverback Therapeutics